Pictet Asset Management’s Sana Biotechnology SANA Stock Holding History

Pictet Asset Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$112K	Hold	32,132	–	–	﹤0.01%	2083
2026 Q1	$92.5K	Buy	32,132 +14,051	+78%	+$55.3K	﹤0.01%	2048
2025 Q4	$73.6K	Buy	+18,081	New	+$81K	﹤0.01%	2052
2025 Q2	–	Sell	-21,325	Closed	-$35.8K	–	2048
2025 Q1	$35.8K	Hold	21,325	–	–	﹤0.01%	1996
2024 Q4	$34.8K	Hold	21,325	–	–	﹤0.01%	2036
2024 Q3	$88.7K	Hold	21,325	–	–	﹤0.01%	1955
2024 Q2	$116K	Buy	21,325 +10,024	+89%	+$79.9K	﹤0.01%	1867
2024 Q1	$113K	Buy	+11,301	New	+$84.7K	﹤0.01%	1866

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Pictet Asset Management's SANA Position: Q2 2026 in Review

Pictet Asset Management held its Sana Biotechnology (SANA) position steady in Q2 2026 at 32,132 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #2083.

Pictet Asset Management first reported a position in SANA in Q1 2024 and has held it in 8 quarters since. The position peaked at $116K in Q2 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Pictet Asset Management held 32,132 shares of Sana Biotechnology worth $112K as of Q2 2026.
Pictet Asset Management left its Sana Biotechnology share count unchanged in Q2 2026.
Sana Biotechnology made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #2083 holding.
Pictet Asset Management first reported a position in Sana Biotechnology in Q1 2024 and has held it in 8 quarters since.
Pictet Asset Management's Sana Biotechnology position peaked at $116K in Q2 2024.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.